| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021.
Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021.
Vidyasagar N, Bunting SR, Arora VM, Ari M.
JAMA. 2024;331(6):524–526. doi:10.1001/jama.2023.26522
https://jamanetwork.com/journals/jama/article-abstract/2814255